Concepedia

Emeline Cros‐Perrial

EC

Statistics

Publications

15

Citations

381

H-Index

12

Active since

2012

Affiliations

Université Claude Bernard Lyon 1(Current)

Inserm

Centre de Recherche en Cancérologie de Lyon

Centre National de la Recherche Scientifique

Centre Léon Bérard

Emeline Cros‐Perrial is an author at Université Claude Bernard Lyon 1 specializing in medicine, drug discovery, and natural sciences.

ORCID

Top concepts

Publications per year

2012–2023

15

Publications

15

Small Molecule Inhibitors of ERCC1-XPF Protein-Protein Interaction Synergize Alkylating Agents in Cancer Cells

Lars Petter Jordheim, Khaled Barakat, Laurence Heinrich-Balard et al. · Molecular Pharmacology · 2013 · 88 citations

Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines

Tormod Bjånes, Lars Petter Jordheim, Jan Schjøtt et al. · Drug Metabolism and Disposition · 2019 · 44 citations · Full text

CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates

Charles Dumontet, Suzanne Peyrottes, Céline Rabeson et al. · European Journal of Medicinal Chemistry · 2018 · 30 citations · Full text

, , +4

Identification and characterization of inhibitors of cytoplasmic 5′-nucleotidase cN-II issued from virtual screening

Lars Petter Jordheim, Zsuzsanna Márton, Moez Rhimi et al. · Biochemical Pharmacology · 2012 · 29 citations

, , +5

The purine analog fludarabine acts as a cytosolic 5′-nucleotidase II inhibitor

Federico Cividini, Rossana Pesi, Laurent Chaloin et al. · Biochemical Pharmacology · 2015 · 23 citations · Full text

, , +9

1–5 of 15